1 The retractions came only months after BioMed Central.
Charlotte J. Haug, M.D Click to read more about the treatment ., Ph.D.1 The retractions came only months after BioMed Central, an open-access publisher owned by Springer, retracted 43 content articles for the same reason. How is it possible to fake peer review? Moon, who studies medicinal vegetation, had set up a simple procedure. He gave journals tips for peer reviewers for his manuscripts, providing them with names and e-mail addresses. But these addresses had been ones he created, therefore the requests to review went directly to him or his colleagues.
Among patients who have been frequently excluded from such research were those with coexisting illnesses, acute myocardial infarction, and multivessel disease. In 2006, a Food and Drug Administration panel formally acknowledged the biohazard of late stent thrombosis, a phenomenon that was observed with an increase of frequency in the populations who was not tested in previous randomized trials of coronary stents. The use and the risk of drug-eluting stents in patients in whom the keeping such stents was regarded as off-label for these devices became a major concern.14,15 It had been suggested that future trials ought to address a broad, unselected patient human population, which will be more representative of everyday clinical practice. Of note, outcomes were constant across all predefined subgroups.